Parties Ask For Summary Judgment In Drug’s Removal From FDA’s Shortage List Case
FORT WORTH, Texas — Motions for summary judgment in a dispute over the U.S. Food and Drug Administration’s removal of semaglutide, an FDA-approved drug for diabetes and weight loss, from the...To view the full article, register now.
Already a subscriber? Click here to view full article